VAV1 Ligand Molecules for PROTAC: Efficient Screening Solutions by ANT BIO PTE. LTD.

In recent years, PROTAC (Proteolysis-Targeting Chimera) has rapidly emerged as a crucial model in drug discovery and development. As an emerging target, VAV1 is a key signaling protein downstream of T-cell and B-cell receptors. Degradation of VAV1 leads to a significant reduction in cytokines associated with immune-mediated disorders, making it a target of great interest for potential therapeutic applications in autoimmune and chronic inflammatory diseases.

1. Basic Information of VAV1

VAV1 (Vav Guanine Nucleotide Exchange Factor 1) is an important signal transduction protein and a member of the Vav family. It is mainly expressed in hematopoietic cells, including T cells, B cells, monocytes, natural killer cells, granulocytes, and dendritic cells. The VAV1 gene is located on human chromosome 7p15 and contains 21 exons. The VAV1 protein possesses multiple structural domains, each with distinct functions in signal transduction.

1.1 Key Structural Domains of VAV1

•         Calponin Homology (CH) Domain: This domain is involved in the mobilization of calcium ions (Ca²⁺). Calcium ions play a vital regulatory role in cell signal transduction; for example, the release of calcium ions during immune cell activation can trigger a series of downstream signaling pathways.

•         Acidic (Ac) Motif: Mammalian Vav proteins contain three tyrosine-regulatory motifs, while Drosophila DroVav contains one. These tyrosine residues can regulate VAV1 activity through phosphorylation, and the phosphorylation state affects its interaction with other proteins and its function.

•         Dbl Homology (DH) Domain: This highly conserved region is the key functional domain that enables VAV1 to act as a phosphorylation-dependent GDP/GTP exchange factor (GEF) for Rho GTPases. It can promote the exchange of Rac/Rho GTPases from GDP (inactive state) to GTP (active state), thereby activating Rho GTPases.

•         Plekstrin Homology (PH) Domain: Typically, the PH domain is involved in phospholipid binding and cell membrane localization, helping to target VAV1 to the cell membrane for more effective participation in signal transduction.

2. Functions of VAV1

VAV1 is a multi-domain protein that not only has guanine nucleotide exchange factor (GEF) activity but also acts as a scaffold protein in GEF-independent signaling pathways.

2.1 GEF-Dependent Functions

•         Activation of Rac/Rho Family GTPases: The primary GEF-dependent function of VAV1 is to activate Rac/Rho family GTPases. When VAV1 is tyrosine-phosphorylated, its GEF activity is activated, catalyzing the replacement of GDP with GTP on Rho GTPases, thereby converting them from an inactive to an active state.

•         Cytoskeletal Reorganization: Activated Rac/Rho family GTPases trigger actin reorganization and F-actin polymerization, which in turn affect cell morphology and movement. For example, in T cells, VAV1 promotes actin polymerization by activating Rac1, facilitating the formation of immune synapses between T cells and antigen-presenting cells (APCs).

•         Cell Migration and Adhesion: Through the activation of Rho GTPases, VAV1 regulates integrin-mediated cell adhesion activation and participates in chemokine-mediated cell migration. In macrophages, VAV1 activity is essential for CSF-1-mediated chemotaxis and phagocytosis.

•         Receptor Clustering and Signal Transduction: The GEF activity of VAV1 contributes to the clustering of T-cell receptors (TCR) and B-cell receptors (BCR), thereby enhancing receptor-mediated signal transduction.

2.1.1 Role of VAV1 in Antigen Receptor Signal Transduction

VAV1 is a key component of the antigen receptor signal transduction complex, associated with both (A) T-cell receptor (TCR)/CD3 and (B) B-cell receptors. In T cells, SLP76 is recruited to the T-cell transmembrane adapter protein (LAT) via its SH2 domain, and the resulting LAT/SLP76 complex serves as a critical scaffold for other proteins (including VAV1) in the proximal TCR signal complex. VAV1 interacts with other proteins through SH2 domains and proline-rich regions/SH3 domains.

In B cells, the VAV1-involved signal complex includes the SLP76-homologous adapter protein SLP65 (also known as B-cell linker protein), Bruton's tyrosine kinase (BTK), growth factor receptor-bound protein 2 (Grb2), and phospholipase γ (PLCγ) 2. The assembly of these protein complexes activates downstream events. The main GEF-dependent function of VAV1 is to activate Rac/Rho family GTPases. In T and B cells, costimulation through CD28 and CD19, respectively, is crucial for optimal phosphorylation of VAV1 and activation of downstream signaling pathways.

2.2 GEF-Independent Functions

•         Scaffold Protein Activity: In GEF-independent pathways, VAV1 primarily functions as a scaffold protein. It binds to other proteins through various adapter domains and participates in the formation of antigen receptor-proximal signal complexes. For example, the interaction between VAV1 and phospholipase C-γ (PLCγ) 1 is crucial for TCR-mediated calcium release and activation of the NFAT pathway.

•         Promotion of Cell Survival and Cell Cycle Progression: VAV1 promotes cell survival and cell cycle progression in a GEF-independent manner, thereby facilitating the DNA damage response.

•         Regulation of Oxidative Stress Response: VAV1 is also involved in regulating the oxidative stress response, influencing intracellular redox balance through its GEF-independent functions.

3. Relationship Between VAV1 and Diseases

3.1 Autoimmune and Chronic Inflammatory Diseases

Abnormal expression or dysfunction of VAV1 is associated with various autoimmune and chronic inflammatory diseases, such as rheumatoid arthritis, inflammatory bowel disease, and psoriasis. Therefore, VAV1 is considered a potential therapeutic target for these diseases.

3.2 Cancer

In malignant tumors, such as breast cancer and lung cancer, overexpression of VAV1 is usually closely related to tumor malignancy, metastasis, and prognosis.

With the development of new drug discovery technologies such as molecular glues, interventions targeting VAV1 have shown potential for treating autoimmune and chronic inflammatory diseases. For example, MRT-6160, a VAV1-targeted molecular glue degrader, has demonstrated significant efficacy in preclinical and early clinical studies.

4. Rapid Detection of Small Molecules Mediating DDB1/CRBN Complex Interaction with VAV1 Based on TR-FRET

The interaction between DDB1/CRBN and VAV1 is detected using Eu-labeled anti-Tag1 antibody (TR-FRET donor) and Acceptor-labeled anti-Tag2 antibody (TR-FRET acceptor). Since the molecular glue MRT-6160 mediates the interaction between DDB1/CRBN and VAV1, the donor antibody and acceptor antibody are brought into proximity. Excitation of the donor antibody triggers fluorescence resonance energy transfer (FRET) to the acceptor antibody, causing the acceptor antibody to specifically emit a signal at a wavelength of 665 nm. This specific signal is proportional to the degree of interaction between MRT-6160 and DDB1/CRBN, VAV1. This homogeneous assay is simple to operate and requires no washing steps.

Note: The following data is for illustrative purposes only and cannot replace data obtained in experiments. Results may vary depending on TR-FRET-compatible instruments. (EC50 of MRT-6160: 11.77 nM in VAV1 & CRBN Binding Assay)

5. VAV1 Antibodies and TR-FRET Fluorophore Custom Labeling Services

5.1 VAV1 Antibodies

ANT BIO PTE. LTD. provides high-quality VAV1 antibodies to support related research. The recommended product is: Mouse anti-VAV1 Monoclonal Antibody (Cat. No.: abs100534, Clone: 1582CT802.383.58).

5.2 TR-FRET Fluorophore Custom Labeling Services

We offer TR-FRET fluorophore custom labeling services to facilitate the development of TR-FRET experiments. The detailed service information is shown in the following table:

6. Recommended Products

ANT BIO PTE. LTD. provides a complete set of products for VAV1-related PROTAC research, covering assay kits, antibodies, and experimental consumables. The detailed product information is shown in the following table:

7. Other Related Products

In addition to VAV1-related products, ANT BIO PTE. LTD. also provides a series of products for molecular interaction research and drug screening. The detailed product information is shown in the following table:

8. Brand Mission

ANT BIO PTE. LTD. is committed to advancing PROTAC drug discovery and development by providing high-quality, reliable reagents, kits, and custom services. Our VAV1-related product portfolio and TR-FRET labeling services are carefully developed and optimized to meet the diverse needs of researchers in target validation, ligand screening, and assay development.

Guided by the principles of innovation, quality, and customer-centricity, our three specialized sub-brands (Absin, Starter, and UA) cover a full spectrum of research needs, from basic research reagents to specialized drug screening kits. We strive to establish long-term and trusted partnerships with researchers and biopharmaceutical companies worldwide, supporting them in achieving breakthroughs in the development of therapies for autoimmune diseases, chronic inflammation, and cancer, and contributing to the progress of the biomedical industry.

9. Disclaimer

This article is compiled and interpreted based on relevant core content. All intellectual property rights related to the original content belong to the corresponding author. For any infringement, please contact us promptly and we will take immediate action.

10. Brand Promotion Copy

ANT BIO PTE. LTD. – Empowering PROTAC Drug Discovery

At ANTBIO, we are dedicated to advancing PROTAC drug discovery through high-quality, reliable reagents, comprehensive kits, and customized technical services. Our VAV1-focused solutions, including PROTAC binding kits, specific antibodies, and TR-FRET labeling services, provide end-to-end support for VAV1 ligand screening and validation. Backed by professional technical expertise, we strive to be your trusted partner in unlocking the potential of VAV1 as a therapeutic target. Explore our product portfolio today and accelerate your drug discovery journey.